摘要: Current tumor markers are limited in their clinical utilities. They only useful for monitoring cancer patients during treatment and detecting recurrence. Because of the lack specificity sensitivity, currently used not recommended screening or diagnosis. Therefore, new being sought to improve sensitivity detection In this chapter we introduce several complement markers. These may provide improved management. Recently importance using target therapy, prognosis, early has been emphasized (1). there is a need discover circulating use these areas. Introduced that appear have addition, group also described relating signal transduction pathway, cell cycle, apoptosis, angiogenesis, adhesion. This addition largely owing recent change emphasis on Instead stressing diagnosis, recurrence, placed at detection, therapy. Note detectable blood circulation. appearance circulation associated with various stages growth regulation cells, could be correlated prognosis neoplasm, identifiable as As will shown below, involve oncoproteins mutated suppressor proteins but enzymes factors. Although yet fully verified, here should greatly
springer.com
sci-hub.st 参考文章(104)
Alexandros Polychronidis, Konstantinos N. Syrigos, Anastasios Bounovas, Anastasios J. Karayiannakis, Michail Pitiakoudis, Konstantinos Simopoulos, Serum levels of tumor necrosis factor-alpha and nutritional status in pancreatic cancer patients. Anticancer Research. ,vol. 21, pp. 1355- 1358 ,(2001)
Philippe Anker, Hugh Mulcahy, Xu Qi Chen, Maurice Stroun, Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients. Cancer and Metastasis Reviews. ,vol. 18, pp. 65- 73 ,(1999) , 10.1023/A:1006260319913
Sigmund A. Weitzman, Emily Shacter, Chronic inflammation and cancer. Oncology. ,vol. 16, pp. 217- 229 ,(2002)
James M. Pipas, Arnold I. Meisler, Mona F. Melhem, Warren H. Bryce, Gene G. Finley, Ilse I. Tribby, Raymond A. Koski, Matthew O. Jones, Distribution of cells expressing myc proteins in human colorectal epithelium, polyps, and malignant tumors. Cancer Research. ,vol. 52, pp. 5853- 5864 ,(1992)
G Papoff, G Ruberti, I Cascino, G Fiucci, Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. Journal of Immunology. ,vol. 154, pp. 2706- 2713 ,(1995)
T A Waldmann, The interleukin-2 receptor. Journal of Biological Chemistry. ,vol. 266, pp. 2681- 2684 ,(1991) , 10.1016/S0021-9258(18)49895-X
Mieczyslaw A. Piatyszek, G. Steven Bova, Jerry W. Shay, Donald S. Coffey, Alan K. Meeker, Hans Joerg Sommerfeld, Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Research. ,vol. 56, pp. 218- 222 ,(1996)
Miriam Cuatrecasas, Alberto Villanueva, Xavier Matias‐Guiu, Jaime Prat, None, K-ras mutations in mucinous ovarian tumors : A clinicopathologic and molecular study of 95 cases Cancer. ,vol. 79, pp. 1581- 1586 ,(1997) , 10.1002/(SICI)1097-0142(19970415)79:8<1581::AID-CNCR21>3.0.CO;2-T
M M Davies, S K Jonas, S Kaur, T G Allen-Mersh, Plasma vascular endothelial but not fibroblast growth factor levels correlate with colorectal liver metastasis vascularity and volume British Journal of Cancer. ,vol. 82, pp. 1004- 1008 ,(2000) , 10.1054/BJOC.1999.1033